Last $69.75 USD
Change Today +0.33 / 0.48%
Volume 358.0K
DVA On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 12:42 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (DVA) Snapshot

Open
$69.59
Previous Close
$69.42
Day High
$70.00
Day Low
$69.25
52 Week High
03/21/14 - $70.68
52 Week Low
11/6/13 - $52.75
Market Cap
14.9B
Average Volume 10 Days
1.2M
EPS TTM
$4.09
Shares Outstanding
213.2M
EX-Date
--
P/E TM
17.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for DAVITA HEALTHCARE PARTNERS I (DVA)

davita healthcare partners i (DVA) Related Businessweek News

View More BusinessWeek News

davita healthcare partners i (DVA) Details

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of December 31, 2013, it operated or provided administrative services through a network of 2,074 outpatient dialysis centers in the United States; and 73 outpatient dialysis centers located in 10 countries outside the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.

57,400 Employees
Last Reported Date: 02/21/14
Founded in 1994

davita healthcare partners i (DVA) Top Compensated Officers

Co-Chairman and Chief Executive Officer
Total Annual Compensation: $1.3M
Chief Executive Officer of Kidney Care Divisi...
Total Annual Compensation: $776.4K
Chief Accounting Officer, Vice President and ...
Total Annual Compensation: $686.9K
Chief Legal Officer and Corporate Secretary
Total Annual Compensation: $716.0K
Compensation as of Fiscal Year 2012.

davita healthcare partners i (DVA) Key Developments

Davita Labs Expands to Create 100 Jobs

DaVita Labs is expanding its laboratory operations in DeLand to accommodate future employee growth. DaVita is a division of DaVita HealthCare Partners Inc. The project will create 100 jobs and generate nearly $32 million in capital investment in the community over five years. The project will also retain 350 jobs already in DeLand.

Independence Blue Cross and DaVita Healthcare Partners Announce Joint Venture

Independence Blue Cross and DaVita HealthCare Partners announced the creation of Tandigm Health. This unique joint venture, based in Philadelphia, Pa., will help deliver high-quality, affordable care to the region by combining the expertise of one of the country's largest, most innovative Blue insurers and a nationally recognized pioneer of physician-centric coordinated care.

Davita Healthcare Partners Inc. Announces Executive Changes

DaVita HealthCare Partners Inc. has announced that Javier Rodriguez will move from president to CEO of the company's kidney care division. Kent thiry will remain CEO of the company as well as co-chairman of the board of directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $69.76 USD +0.335

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Labs Inc $26.74 USD -0.32
Fresenius Medical Care AG & Co KGaA €49.71 EUR +0.04
Genomic Health Inc $26.61 USD -0.15
Laboratory Corp of America Holdings $100.41 USD +0.56
Myriad Genetics Inc $40.68 USD +1.00
View Industry Companies
 

Industry Analysis

DVA

Industry Average

Valuation DVA Industry Range
Price/Earnings 24.0x
Price/Sales 1.2x
Price/Book 3.3x
Price/Cash Flow 12.7x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit www.davita.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.